Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II booster study of investigational DTPw-HBV-IPV/Hib vaccine formulations in healthy toddlers
2016-000645-31Phase 2
- Sponsor
- GSK
- Start
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of diphtheria and tetanus toxoids and pertussis, hepatitis B, poliovirus, and Haemophilus influenzae type b vaccine, Tritanrix-HepB, haemophilus influenzae type b vaccine and Poliorix in poliomyelitis (4 arms), sponsored by GSK. Primary endpoint: Immunogenicity with respect to the components of the study vaccines.
02
Drugs
diphtheria and tetanus toxoids and pertussis, hepatitis B, poliovirus, and Haemophilus influenzae type b vaccineTritanrix-HepBhaemophilus influenzae type b vaccinePoliorix
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2016-000645-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000645-31.